This appropriation covers: - expenditure to Rapporteurs and Co-rapporteurs on specialised studies and consultations contracted out to highly qualified experts (individuals or firms), as provided for in Article 62(3) of Regulation (EC) No 726/2004; purchase of consultancy services if the Agency does not have suitable staff available to be involved with the scientific evaluation of applications; - studies already carried out or subscriptions from to specialist research institutions - payments for testing and sampling by the official medicines control laboratory under the European Department for Quality of Medicines of the European Pharmacopoeia